Crohn’s disease is a chronic inflammatory bowel disease that has no cure. It causes abdominal pain, frequent diarrhea, weight loss, fatigue, and anemia. While the disease can be controlled to some degree through oral and injectable medications, life-threatening complications may occur.
One of the feared complications of Crohn’s disease is called a bowel fistula. A fistula is an abnormal connection between two places on the body. In Crohn’s disease, a fistula forms between the intestine and some other structure—the intestine essentially forms a “tunnel.” The fistula can form between one loop of intestine and another, between intestine and bladder, or even between the intestine and the outside of the body. This complication of Crohn’s disease is obviously quite distressing to patients.
Some bowel fistulas may close on their own with conservative treatments, but fistulas associated with Crohn’s disease do not respond well to available medical treatments. Those looking for an alternative treatment may be able to consider stem cell therapy.
Stem cells offer an interesting potential solution to this problem. Stem cells can provide a large dose of normal cells filled with molecules that can help direct normal bowel growth and development. Indeed, researchers have shown that autologous mesenchymal stem cells can help close and heal fistulas in patients with Crohn’s disease.
In phase I, II, and IIB clinical trials, stem cells derived from adipose tissue or bone marrow were directly infused into the bowel area (via a so-called intra-fistular injection). Across five clinical studies including over 100 patients, stem cell administration resulted in complete fistula healing in 50 to 80% of patients treated. Of those who did not obtain complete control fistula closure, almost all had evidence of improvement. These results support that autologous mesenchymal stem cell therapy is a promising future treatment for patients with Crohn’s disease and may offer patients enjoy a better quality of life.
Ulcerative colitis and Crohn’s disease, together known as inflammatory bowel disease, are chronic disorders of the lower digestive tract that cause patients considerable difficulty and discomfort. Patients generally go through periods of normalcy punctuated by relapses. In cases of inflammatory bowel disease, patients may experience severe, and sometimes bloody diarrhea. Patients also experience crampy abdominal pain, the urgent need to defecate, pain with defecation and even fecal incontinence. Consequently, people with inflammatory disease often endure substantial amounts of suffering.
Inflammatory bowel disease is usually treated with 5-aminosalicylate or sulfasalazine. These drugs are intended to reduce inflammation in the bowels. Relapses do still occur for those patients taking these medicines. During these relapses, patients often need to take steroids for short or intermediate periods of time but over time, side effects can occur. Immunomodulators such as azathioprine, 6-mercaptopurine, and methotrexate can be used to reduce inflammation, however, these drugs can also cause side effects. Newer biologic response modifiers have helped people with severe inflammatory bowel disease but they may weaken the body’s immune system, making it more difficult to fight off infection. For these reasons, safer and more effective treatments for inflammatory bowel disease are needed.
Fortunately, researchers have conducted a number of clinical studies examining the role of stem cells in the treatment of inflammatory bowel disease. The most promising results have come from allogeneic mesenchymal stem cell therapy using stem cells derived from the umbilical cord. Research has found that allogeneic mesenchymal stem cells injected into a vein were able to induce a clinical response 3 out of 9 patients tested. One patient had complete clinical remission. In all cases, the stem cells increased the quality of life for patients. Five out of seven patients with inflammatory bowel disease had clinical remission after stem cell treatment. Likewise, further research showed that the stem cells could induce a clinical response and 12 of 15 patients and full clinical remission in eight of them. Here too, patients reported improved quality of life with stem cell treatment.
These results are incredibly promising and offer hope to patients struggling with ulcerative colitis and Crohn’s disease. While more research is needed, patients with inflammatory bowel disease should follow this field closely for new developments.
Silicosis, which is also known as miner’s phthisis, potter’s rot grinder’s asthma, potter’s rot, is an occupational disease of the lungs that is caused by the inhalation of a specific type of dust called crystalline silica dust. The disease causes inflammation and scarring in the lungs that leads to the formation of lesions. The disease has been increasing in incidence in developing countries in recent years and unfortunately cannot be fully cured.
A recent study, published in Stem Cell Research & Therapy, explored, for the first time, the potential to intervene in processes associated with silicosis. Stem cell therapy has been used to address inflammation and the resulting tissue damage. Mesenchymal stem cells have been applied to other occupational conditions as well. The researchers hypothesized that adipose-derived mesenchymal stem cells would improve pulmonary fibrosis by reducing inflammation.
Through their study, they found that using these adipose-derived mesenchymal stem cells in silicosis did indeed lead to a remissive effect with regard to pulmonary fibrosis. Further, they found that this occurred by reducing inflammation by modifying protein certain cellular pathways that decreased the expression of problematic proteins.
While this data is preliminary, they show the potential promise of stem cells in the therapeutic intervention of silicosis. Future studies will help researchers and clinicians better understand how stem cells can be used to combat the pulmonary fibrosis associated with silicosis, as well as how they can be used to combat other occupational diseases.
While most approaches to stem therapy involve infusing purified stem cells into the body, Thom and fellow researchers have shown that hyperbaric oxygen therapy (HBOT) is capable of stimulating the body to produce its own stem cells. Thom, Heyboer, and co-authors have extended this work by showing that by slightly increasing the pressures used during hyperbaric oxygen therapy, one can significantly increase the number of stem cells produced.
In his original work, Thom and colleagues showed that a single, two-hour session of 2.0 atmospheres (atm) pressure (twice the air pressure we normally feel at sea level) was capable of doubling the number of stem cells in the bloodstream. Twenty treatments increased stem cell levels by 800%. To study this phenomenon more closely, Thom’s research group recruited 20 patients to undergo hyperbaric oxygen treatment, some at the original 2.0 atm pressure, and some at 2.5 atm. The primary goal of this research was to find out whether a higher pressure was capable of eliciting a greater number of cells.
As before, treatment with 2.0 atm of hyperbaric oxygen substantially increased the number of stem cells found in the blood. However, treatment with 2.5 atm doubled or even tripled the number of stem cells produced compared to the 2.0 atm treatment session. In other words, a slightly higher pressure causes the body to produce substantially more of its own stem cells.
Researchers focused on two types of stem cells, in particular, CD34+ and CD45-dim—markers that appear on stem cells and/or progenitor cells. They are primarily found on cells in the bone marrow. Stem cells with CD45-dim generally go on to become bone, blood, or blood vessel cells, while CD34+ cells can differentiate into almost any cell. Hyperbaric oxygen therapy is thought to stimulate the bone marrow to produce and release these stem cells into the bloodstream, which is the reason these treatments raise stem cell levels in the blood.
The results published by Thom and coworkers suggest that patients who wish to enhance the number of stem cells should consider undergoing hyperbaric oxygen therapy. Furthermore, the greatest number of stem cells was observed after 20 treatment sessions, suggesting that a greater effect occurs with more treatments.
Colostrum is the milk produced by the mammary glands during pregnancy prior to giving birth. It is rich in antibodies that help prevent the newborn from various conditions. Colostrum as compared to normal milk contains a high amount of nutrients and fat, making it highly beneficial.
The most important thing to know about colostrum is that it is not a medication. It is a naturally designed food that maintains the health and prevents conditions. Colostrum is effective for shutting down the onset of conditions and infections, which helps the body to repair itself and allows the individual to enjoy a healthy and radiant life.
Colostrum is the Key to Gut Health
Colostrum is the source of everything that is required to maintain a healthy gastrointestinal tract. It is known that most of our conditions take birth in the gut and proper absorption of nutrients is the key to great health. It is one of the primary function of colostrum to maintain a healthy gut, which is the basis of the overall healthy body.
When the beneficial bacteria present in our intestine is outnumbered by the harmful bacteria then our gut is said to be out of balance. This imbalance has many consequences, one of which is the leaky gut syndrome.
Leaky gut syndrome is a condition due to which various pathogens and toxins pass through the lining of the gut and move freely in the body, this leads to various conditions. Leaky gut syndrome, if not treated can be a life-threatening condition.
Colostrum is an optimal treatment for treating leaky gut syndrome because it has growth factors that help repair the damage of the intestine to normal. It is also rich in immunoglobulins that control the pestering of fungi and bacteria in the body. In various conducted studies colostrum has successfully increased the surface area of the lining of the intestine, thereby improving the absorption of nutrients.
Colostrum: The Perfect & Functional Food
Looking at all the immune and growth factors that are present in colostrum, it is called the best alternative to pharmaceutical drugs, from steroids and antibiotics. Colostrum is also safe for people suffering from lactose intolerance and has no allergic reactions or side effects.
A functional food is one that has potential health benefits compared to normal food and is high in nutrients. Colostrum is high in nutrients and can be combined with other food products. It is most effective when taken on an empty stomach. Available in the form of capsules, colostrum is more effective and bioavailable.
Colostrum for Autoimmune Conditions:
Autoimmune conditions are those in which the body starts producing antibodies against itself. Colostrum has shown to be highly effective to treat autoimmune conditions like Lupus, Parkinson’s disease, and Multiple Sclerosis. Chemokine receptors have been observed to be the cause of the development of all these conditions. Colostrum produces antagonists of these receptors and has been shown to decrease the symptoms of many common autoimmune conditions.
Colostrum Used as a Topical Application:
Colostrum, if applied externally can help heal the burns, acne, cuts and various abrasions and even surgical cuts. If applied orally, it can help deal with sensitive teeth relieve canker sores and gingivitis.
Some Overall Benefits of Colostrum are:
Below is a list of some common conditions for which colostrum can be effective:
If you have any symptoms suggestive of gastro-intestinal dysbiosis (diarrhea, constipation, bloating, reflux, stomach discomfort or pain) then you should seek further work-up by your physician or a Functional Medicine Doctor.
In the meantime, it is recommended to start using Bovine Colostrum which can be found at Sovereign Laboratories at www.mysovlabs.com. Simply mix 2 tablespoons in 6oz of water and consume twice per day on an empty stomach. This product is full of gut healing immunoglobulins. Use for 2-3 months should result in significant improvement.
In addition, it is also recommended to take a good probiotic while using your bovine colostrum. Vitamin D levels should be optimized to levels between 80-100.
Under normal circumstances, pain receptors react to painful stimuli such as burns or lacerations. Pain receptors from the body then send that information along nerves to the brain via electrical signals. Once that electrical information reaches the brain (which happens almost immediately), it is perceived as pain. This type of pain is a nociceptive pain.
Neuropathic pain, however, is different. Neuropathic pain is caused by a condition of the nerves themselves. Patients with neuropathic pain experience chronic pain without any specific injury. Neuropathic pain may be felt as a burning sensation, tingling, or a “pins and needles” sensation, or these combined. Neuropathic pain most often occurs in people with diabetes, certain vitamin deficiencies, and shingles. It may also occur after people receive certain cancer treatments following a stroke.
While it is rather simple to treat pain caused by a burn or laceration (nociceptive pain), it is very difficult to effectively treat neuropathic pain. Standard treatments for neuropathic pain include anti-epilepsy medications such as phenytoin, gabapentin, or carbamazepine and antidepressants such as venlafaxine, duloxetine, or amitriptyline. Usually, these treatments are only modestly effective. Eventually, many patients need powerful opioid medications like morphine and oxycodone to control their pain.
Researchers at the Cleveland Clinic published research that strongly suggests that stem cells may be able to improve those battling neuropathic pain. Dr. Jianguo Cheng and his research group have shown that mesenchymal stem cell transplantation into the spinal fluid can reduce pain and pain sensitivity in an animal model of neuropathic pain. In one series of experiments, they showed that mesenchymal stem cells could relieve pain in rats who had experimental nerve damage. Researchers confirmed the benefit of stem cells for neuropathic pain in several different sets of experiments. The results have been so encouraging that Dr. Cheng and the Cleveland Clinic have applied to patent the technology.
Dr. Cheng’s group also showed intravenously administered mesenchymal stem cells are just as effective as cells administered into the spinal fluid (intrathecally). This is good news for patients since it is less invasive to put stem cells into a vein than it is to infuse them into the cerebrospinal fluid. Amazingly, the research group showed that stem cells injected through either route (vein or spinal fluid) ended up finding their way to damaged nerves where they could provide maximum benefit.
While this work in animals must be performed in humans to confirm the results, this preclinical research establishes a strong foundation for those clinical studies. These results provide hope to those who struggle with daily neuropathic pain.
This website and its contents are not intended to treat, cure, diagnose, or prevent any disease. Stemedix, Inc. shall not be held liable for the medical claims made by patient testimonials or videos. They are not to be viewed as a guarantee for each individual. The efficacy for some products presented have not been confirmed by the Food and Drug Administration (FDA).
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.